These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29694854)

  • 21. Naringenin Modifies the Development of Lineage-Specific Effector CD4
    Wang J; Niu X; Wu C; Wu D
    Front Immunol; 2018; 9():2267. PubMed ID: 30327657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,25-dihydroxyvitamin D
    Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
    Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astragaloside IV regulates differentiation and induces apoptosis of activated CD4
    Yang L; Xing F; Han X; Li Q; Wu H; Shi H; Wang Z; Huang F; Wu X
    Toxicol Appl Pharmacol; 2019 Jan; 362():105-115. PubMed ID: 30385269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases.
    Sun X; Wasley JW; Qiu J; Blonder JP; Stout AM; Green LS; Strong SA; Colagiovanni DB; Richards JP; Mutka SC; Chun L; Rosenthal GJ
    ACS Med Chem Lett; 2011 May; 2(5):402-6. PubMed ID: 24900320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
    Prasad R; Giri S; Nath N; Singh I; Singh AK
    Glia; 2007 Jan; 55(1):65-77. PubMed ID: 17019693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11-mediated protection of regulatory T cells.
    Mondal S; Jana M; Dasarathi S; Roy A; Pahan K
    Sci Signal; 2018 Nov; 11(558):. PubMed ID: 30482850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
    Haghmorad D; Amini AA; Mahmoudi MB; Rastin M; Hosseini M; Mahmoudi M
    J Neuroimmunol; 2014 Dec; 277(1-2):85-95. PubMed ID: 25457839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.
    Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH
    Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
    Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
    Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of autoreactive CD4 T cells by FoxO1 signaling in CNS autoimmunity.
    Kraus EE; Kakuk-Atkins L; Farinas MF; Jeffers M; Lovett-Racke AE; Yang Y
    J Neuroimmunol; 2021 Oct; 359():577675. PubMed ID: 34403862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O-Aminobenzoyl-S-nitrosoglutathione: A fluorogenic, cell permeable, pseudo-substrate for S-nitrosoglutathione reductase.
    Sun BL; Palmer L; Alam SR; Adekoya I; Brown-Steinke K; Periasamy A; Mutus B
    Free Radic Biol Med; 2017 Jul; 108():445-451. PubMed ID: 28419866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anlotinib attenuates experimental autoimmune encephalomyelitis mice model of multiple sclerosis
    Zhu H; Li G; Yin J; Zhang H; Da Y; Li L
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):594-602. PubMed ID: 35638564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total Flavonoids of Astragalus Inhibit Activated CD4[Formula: see text] T Cells and Regulate Differentiation of Th17/Th1/Treg Cells in Experimental Autoimmune Encephalomyelitis Mice by JAK/STAT and NF[Formula: see text]B Signaling Pathways.
    Han XY; Xu N; Yuan JF; Wu H; Shi HL; Yang L; Wu XJ
    Am J Chin Med; 2023; 51(5):1233-1248. PubMed ID: 37385966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
    Bodas M; Silverberg D; Walworth K; Brucia K; Vij N
    Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enhancement of regulatory T cell induction by intravenous S-sulfonated Immunoglobulin during the treatment of experimental autoimmune encephalomyelitis].
    Okuda S; Kamei S; Harano S; Shinya N; Hayashida K; Sasaki T
    Yakugaku Zasshi; 2012; 132(2):243-9. PubMed ID: 22293707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities.
    Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Blonder JP; Colagiovanni DB; Mutka SC; Stout AM; Richards JP; Rosenthal GJ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5849-53. PubMed ID: 21855338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
    Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
    Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.